About Tigermed

Our Company

Media & Resources

Press Releases

Events

Tigermed Insights

Resource Library

Cloud Classroom

Environment, Social and Governance (ESG)

Sustainability & ESG Report

ESG Management

Corporate Responsibility

Corporate Video

We are committed to supporting our clients in their clinical development in the best possible way.

By Phase

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

Preclinical Development

Medicinal Chemistry

Medical Writing

Data Management and Statistical Analysis

Clinical Development Strategy

Decentralized Clinical Trials (DCTs)

Site Management (SMO)

Medical Device / IVD

Multi-region Clinical Trial (MRCT)

Vaccine Clinical Trial

Integrated Capabilities

Medical Imaging

Functional Service Provider (FSP)

Recruitment Management

EDC System

Remote Follow-up Center

Therapeutic Expertise

Cell and Gene Therapy

Central Nervous System

Gastroenterology

Ophthalmology

Careers

Talent Development

Enjoy Your Life with Tigermed

Join Tigermed

Global Locations

Discover our offices across Asia, US, Europe, Latin America and Africa.

Career Opportunities

Explore your career opportunities worldwide with Tigermed.

Investors

Corporate Governance

Financial Reports and Presentations

Announcements

Prospectus

Investor Contact

Tigermed 2024 Interim Results Presentation

View Tigermed 2024 Interim Results Presentation

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Contact

Business Enquiry / RFP

Client Service Center

Media & Investors Enquiry

Compliance Concern

Business Enquiry / RFP

Email: marketing@tigermedgrp.com

Client Service Center

Email：clientservice@tigermedgrp.com
Tel：+86 400 070 7751

Media & Investors Enquiry

Email：PR@tigermedgrp.com

Compliance Concern

Email: compliance.officer@tigermedgrp.com

QUICK LINKS

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

About Tigermed

Our Company

Advancing human health by delivering life-changing therapies.

Since its inception in 2004, Tigermed (300347.SZ/3347.HK) has been a trusted clinical research organization that provides full-service for the global biopharmaceutical and medical device industries. We are devoted to serving our customers in their clinical development journey efficiently and cost-effectively. For nineteen years, we have been accelerating the launch of innovative healthcare products with our quality, solutions, teams, experience, and expertise, to advance human health.

Global Employees

10,000+

Global Customers

3,200+

Global Offices and Locations

180+

Chinese Innovative Drugs Involved

117

A Full Service CRO for Healthcare Innovation

Whether you are developing a small molecule or biologic, a vaccine or medical device, we have tailored solutions to move your research forward.

Small Molecule

Biologics

Cell & Gene Therapy

Medical Device

Rare Disease

Vaccine

A Global Presence

Tigermed represents a worldwide network of professional clinical experts. We have more than 100 subsidiaries and 180 offices and sites, with over 10,000 employees across a dozen of countries in Asia Pacific, Europe, North & South America and Africa.